11 – 20 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
α-Synuclein-induced deformation of small unilamellar vesicles
- Contribution to journal › Article
- 2021
-
Mark
From iPS Cells to Rodents and Nonhuman Primates : Filling Gaps in Modeling Parkinson's Disease
- Contribution to journal › Article
-
Mark
Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
- Contribution to journal › Article
-
Mark
Cooperativity of α-Synuclein Binding to Lipid Membranes
- Contribution to journal › Article
-
Mark
Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions
- Contribution to journal › Article
- 2020
-
Mark
The properties of α-synuclein secondary nuclei are dominated by the solution conditions rather than the seed fibril strain
- Contribution to journal › Article
-
Mark
Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson’s Disease and Related Diseases
- Contribution to journal › Article
-
Mark
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course - A joint PhD student course at University College London and University of Gothenburg
- Contribution to journal › Scientific review
-
Mark
The role of glia in Parkinson's disease : Emerging concepts and therapeutic applications
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2019
-
Mark
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson’s disease patients
(2019) In Proceedings of the National Academy of Sciences of the United States of America 116(30). p.15226-15235
- Contribution to journal › Article
